ES2119992T3 - Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). - Google Patents

Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).

Info

Publication number
ES2119992T3
ES2119992T3 ES94900935T ES94900935T ES2119992T3 ES 2119992 T3 ES2119992 T3 ES 2119992T3 ES 94900935 T ES94900935 T ES 94900935T ES 94900935 T ES94900935 T ES 94900935T ES 2119992 T3 ES2119992 T3 ES 2119992T3
Authority
ES
Spain
Prior art keywords
pct
mgmt
hybridoma ecacc
nov
date jun
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94900935T
Other languages
English (en)
Inventor
Benjamin Fuk Loi Li
Teck Choon Ayi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Molecular and Cell Biology
Original Assignee
Institute of Molecular and Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute of Molecular and Cell Biology filed Critical Institute of Molecular and Cell Biology
Application granted granted Critical
Publication of ES2119992T3 publication Critical patent/ES2119992T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

EL PRESENTE INVENTO PROPORCIONA ANTICUERPOS CAPACES DE DISCRIMINAR ENTRE MGMT HUMANO Y UNA FORMA ALQUILATADA DE LUGAR ACTIVO DE ESTA ENZIMA EN UN PROCEDIMIENTO DE INMUNOPRECIPITACION. LOS ANTICUERPOS MONOCLONALES CON ESTA CAPACIDAD DE DISCRIMINACION SE OBTIENEN DE HIBRIDOMA ECACC 92112510 E HIBRIDOMA ECACC 93112514, QUE FUERON DEPOSITADOS EN LA COLECCION EUROPEA DE CULTIVOS DE CELULAS ANIMALES, REINO UNIDO BAJO EL TRATADO DE BUDAPEST EN 25 DE NOVIEMBRE DE 1992 Y 25 DE NOVIEMBRE DE 1993, RESPECTIVAMENTE. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 92112510 SE HA DENOMINADO MAB 5H7. EL ANTICUERPO MONOCLONAL DE HIBRIDOMA ECACC 93112514 SE HA LLAMADO MAB 3C7.
ES94900935T 1992-11-27 1993-11-29 Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt). Expired - Lifetime ES2119992T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929224888A GB9224888D0 (en) 1992-11-27 1992-11-27 Monoclonal antibody

Publications (1)

Publication Number Publication Date
ES2119992T3 true ES2119992T3 (es) 1998-10-16

Family

ID=10725777

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94900935T Expired - Lifetime ES2119992T3 (es) 1992-11-27 1993-11-29 Anticuerpos especificos de 6-o-metilguanina-adn-metiltransferasa (mgmt).

Country Status (10)

Country Link
US (1) US5817514A (es)
EP (1) EP0670908B1 (es)
AT (1) ATE169680T1 (es)
AU (1) AU688289B2 (es)
CA (1) CA2149867A1 (es)
DE (1) DE69320364T2 (es)
ES (1) ES2119992T3 (es)
GB (1) GB9224888D0 (es)
SG (1) SG48841A1 (es)
WO (1) WO1994012660A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase
AU2001296511A1 (en) * 2000-09-29 2002-04-08 The Johns Hopkins University School Of Medicine Method of predicting the clinical response to chemotherapeutic treatment with alkylating agents
IL157880A0 (en) * 2001-04-10 2004-03-28 Ecole Polytech Methods using o6-alkylguanine-dna alkyltransferases
AU2007207465B2 (en) 2006-01-18 2012-12-06 Merck Patent Gmbh Specific therapy using integrin ligands for treating cancer
BRPI0806596A2 (pt) 2007-01-18 2013-07-23 Merck Patent Ges Mit Berchraenkter Haftung medicamento e terapia especÍfica usando-se ligantes de integrina para o tratamento de cÂncer
NZ580982A (en) 2007-05-08 2012-05-25 Schering Corp Methods of treatment using intravenous formulations comprising temozolomide
WO2009154461A1 (en) * 2008-06-19 2009-12-23 Prothix Bv Use of anti-factors xi antibodies for prevention of thrombus formation
EP2445534A2 (en) 2009-05-25 2012-05-02 Merck Patent GmbH Continuous administration of cilengitide in cancer treatments
AU2011278700A1 (en) 2010-07-16 2013-02-28 Merck Patent Gmbh Peptide for use in the treatment of breast cancer and/or bone metastases
CA2854857C (en) * 2011-11-25 2020-01-07 Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V. Monoclonal antibody for the detection of snap/clip tag
JP6215223B2 (ja) 2011-12-09 2017-10-18 アンスティテュ・パストゥール マルチプレックス免疫スクリーニングアッセイ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407804A (en) * 1992-05-22 1995-04-18 Applied Genetics Inc. Assays for O6 -methylguanine-DNA methyltransferase

Also Published As

Publication number Publication date
WO1994012660A1 (en) 1994-06-09
SG48841A1 (en) 1998-05-18
US5817514A (en) 1998-10-06
EP0670908A1 (en) 1995-09-13
AU688289B2 (en) 1998-03-12
ATE169680T1 (de) 1998-08-15
GB9224888D0 (en) 1993-01-13
EP0670908B1 (en) 1998-08-12
DE69320364T2 (de) 1998-12-10
DE69320364D1 (de) 1998-09-17
AU5570594A (en) 1994-06-22
CA2149867A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
DE69429095D1 (de) Humanisierte antikoerper
MY121464A (en) Antibodies against human cd40
FR12C0004I2 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
ATE418562T1 (de) Ctl epitope des epstein-barr virus
AR248044A1 (es) Una secuencia de adn que codifica anticuerpos monoclonales humanizados contra interleuquinas humanas, metodo de obtencion y de seleccion de dichos anticuerpos, vector recombinante y celula huesped.
ATE212038T1 (de) Humanisierte monoklonale anti-cd40 antikörper und fragmente zur hemmung der b-zellaktivierung
DE69320364D1 (de) 6-o-methylguanin-dna-methyltransferase (mgmt) spezifische antikörper
ATE316137T1 (de) Humanisierte antikörper gegen den epidermalen wachstumsfaktorrezeptor
DK0626447T3 (da) Monoklonale antistoffer og Fv, som er specifikke for CD2-antigen
MX9704898A (es) Anticuerpo anti-idiotipo monoclonal murino 3h1.
AU3045497A (en) Human monoclonal antibody against hepatitis b virus surface antigen (hbvsag)
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
GR3029483T3 (en) Antibodies against t-cells as therapeutics
AU4326693A (en) Monoclonal antibodies to glycoprotein p
NO972522L (no) Monoklonale antistoffer med immunoundertrykkende aktivitet
DE59812529D1 (de) Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2
BR9305557A (pt) Anticorpos monoclonais humanos anti Rhesus-D e composiçao farmacêutica que os contém
DE69533504D1 (de) Monoklonale antikörper gegen antigene, die durch hämatopoietische helferzellen exprimiert werden
GB2284608A (en) 06-Methylguanine-DNA-methyltransferase (mgmt) specific antibodies
DK0569537T3 (da) Monoklonale antistoffer mod formodede HCV-kapperegioner og fremgangsmåder til anvendelse deraf
Leanderson et al. Effects of μ‐specific antibodies on B cell growth and maturation
FI974018A0 (fi) Ihmisen 2 integriini -alayksikkö
ATE251643T1 (de) Antikörper 67d2 gegen cd164
RU98104739A (ru) Штамм культивируемых клеток мышиной гибридомы, используемый для получения моноклональных антител к ядрышковому антигену, ассоциированному с клеточной пролиферацией
NO172549C (no) Monoklonalt humanurokinase-antistoff, immunoabsorberende middel for rensing av humanurokinase samt anvendelse av antistoffet for detektering av humanurokinase

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 670908

Country of ref document: ES